In the modern examine, we described the identification as well as the characterization of a new atypical opioid receptor with exclusive adverse regulatory properties in the direction of opioid peptides.1 Our outcomes confirmed that ACKR3/CXCR7, hitherto generally known as an atypical scavenger receptor for chemokines CXCL12 and CXCL11, can https://spiron257plf6.iyublog.com/profile